Institute Happenings Five Innovative Projects Receive 2025 Seed Grants DDI has awarded 2025 Seed Grants to research teams advancing innovative drug discovery. This year’s… New Cancer Biomarker Facility to be Housed at UH Drug Discovery Institute UH Receives $3M from CPRIT to set up a Cancer Immunotherapy Biomarker Core. University of Houston Pathways to Impactful Medicines The UH Drug Discovery Institute hosts Sharath Hegde of Congruence Therapeutics. Lipid Engineering to Create New Therapeutics and Other Products The UH Drug Discovery Institute hosts Dan Monticello of GlycosBio. Discovery and Optimization of Small Molecule Drug Leads and Probes The UH Drug Discovery Institute hosts John Buolamwini of Rosalind Franklin University. Immunological Memory in Weight Cycling Heather Caslin poses the question: is weight loss always good? Optimizing Biologics Development through Computational Modeling David Roush, distinguished scientist at Merck, presents his research to the Drug Discovery Institute… A New Generation of Tubulin Inhibitors Wei Li of the University of Tennessee Health Science Center demonstrates promising research on tubul… Opportunities in Basic and Translational Research In the 21st century, chemical biology has emerged as a discipline central to therapeutic discovery a… Targeting Chronic Infections and Deadly Bacteria UH researcher examines self-digestion mechanism in persister cells. University of Houston
